FDA Inspection 1097950 — US Specialty Formulations LLC

US Specialty Formulations LLC — FEI 3010680515

The FDA completed an inspection of US Specialty Formulations LLC on Jul 23, 2019 in Allentown, PA. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). 11 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI)
End Date
Jul 23, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Allentown, PA (United States)

Citations

IDCFRDescription
113321 CFR 211.25(a)GMP Training Frequency
115921 CFR 211.28(a)Clothing appropriate for duties performed
126321 CFR 211.68(b)Computer control of master formula records
136121 CFR 211.100(a)Absence of Written Procedures
145421 CFR 211.115(a)Reprocessing procedures not written or followed
18008FDCA 503B(a)(10)Drug product label, outsourcer facility
188321 CFR 211.165(a)Testing and release for distribution
189021 CFR 211.165(e)Test methods
189121 CFR 211.165(f)Failing drug products not rejected
435521 CFR 211.165(c)Sampling and testing plans not followed
435721 CFR 211.166(a)Results not used for expiration dates, storage cond.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.